An Autophagy Modulator Peptide Prevents Lung Function Decrease and Corrects Established Inflammation in Murine Models of Airway Allergy
François Daubeuf(Centre National de la Recherche Scientifique), Sylviane Muller(Centre National de la Recherche Scientifique)
Cited by 17
Related Papers
Lysosomes as a therapeutic target
|Nature Reviews Drug Discovery|2019|751
OX40 Ligand Contributes to Human Lupus Pathogenesis by Promoting T Follicular Helper Response
|Immunity|2015|223
Progress and Challenges in the Use of MAP1LC3 as a Legitimate Marker for Measuring Dynamic Autophagy In Vivo
|Cells|2020|44
Targeting the endo-lysosomal autophagy pathway to treat inflammatory bowel diseases
|Journal of Autoimmunity|2022|23
Novel trisaccharide based phospholipids as immunomodulators
|International Immunopharmacology|2019|14